Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Boer

Showing results (131-140 of 138) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 138 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune HepatitisFloris F van den Brand, Koen S van der Veen, Ynto S de Boer, et al.
Genes and Immunity|January 23, 2015
HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1N M F van Gerven, Y S de Boer, A Zwiers, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Gastroenterology|April 29, 2014
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1Ynto S de Boer, Nicole M F van Gerven, Antonie Zwiers, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
The American Journal of Gastroenterology|December 9, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world studyMaria C van Hooff, Rozanne C de Veer, Ellen Werner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2025
Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated CirrhosisPinelopi Arvaniti, Sergio Rodríguez-Tajes, Marlene Padilla, et al.
Pageof 14

Showing results (131-140 of 138) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 138 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune HepatitisFloris F van den Brand, Koen S van der Veen, Ynto S de Boer, et al.
Genes and Immunity|January 23, 2015
HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1N M F van Gerven, Y S de Boer, A Zwiers, et al.
Journal of Hepatology|May 10, 2023
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportRaúl J Andrade, Guruprasad P Aithal, Ynto S de Boer, et al.
Gastroenterology|April 29, 2014
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1Ynto S de Boer, Nicole M F van Gerven, Antonie Zwiers, et al.
Journal of Hepatology|December 15, 2023
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitisRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
Trials|December 13, 2022
Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trialRomée J A L M Snijders, Anna E C Stoelinga, Tom J G Gevers, et al.
The American Journal of Gastroenterology|December 9, 2025
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world studyMaria C van Hooff, Rozanne C de Veer, Ellen Werner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 10, 2025
Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated CirrhosisPinelopi Arvaniti, Sergio Rodríguez-Tajes, Marlene Padilla, et al.
Pageof 14